KR20090028846A - 페닐-치환 피롤리돈 - Google Patents

페닐-치환 피롤리돈 Download PDF

Info

Publication number
KR20090028846A
KR20090028846A KR1020097004694A KR20097004694A KR20090028846A KR 20090028846 A KR20090028846 A KR 20090028846A KR 1020097004694 A KR1020097004694 A KR 1020097004694A KR 20097004694 A KR20097004694 A KR 20097004694A KR 20090028846 A KR20090028846 A KR 20090028846A
Authority
KR
South Korea
Prior art keywords
compounds
hiv
compound
chloro
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020097004694A
Other languages
English (en)
Korean (ko)
Inventor
바오겐 우
트룩 엔. 엔구옌
데이비드 에이. 엘리스
샤오후이 헤
베쓰 엠. 아나클레리오
군용 양
하-순 최
즈이쳉 왕
토마스 마실제
윤 헤
Original Assignee
아이알엠 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아이알엠 엘엘씨 filed Critical 아이알엠 엘엘씨
Publication of KR20090028846A publication Critical patent/KR20090028846A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020097004694A 2005-01-28 2006-01-30 페닐-치환 피롤리돈 Ceased KR20090028846A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64802705P 2005-01-28 2005-01-28
US60/648,027 2005-01-28

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020077017487A Division KR100896889B1 (ko) 2005-01-28 2006-01-30 페닐-치환 피롤리돈

Publications (1)

Publication Number Publication Date
KR20090028846A true KR20090028846A (ko) 2009-03-19

Family

ID=36741146

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020097004694A Ceased KR20090028846A (ko) 2005-01-28 2006-01-30 페닐-치환 피롤리돈
KR1020077017487A Expired - Fee Related KR100896889B1 (ko) 2005-01-28 2006-01-30 페닐-치환 피롤리돈

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020077017487A Expired - Fee Related KR100896889B1 (ko) 2005-01-28 2006-01-30 페닐-치환 피롤리돈

Country Status (11)

Country Link
US (1) US20080287516A1 (https=)
EP (1) EP1841425A4 (https=)
JP (1) JP2008528624A (https=)
KR (2) KR20090028846A (https=)
CN (1) CN101115481A (https=)
AU (1) AU2006209245A1 (https=)
BR (1) BRPI0606123A2 (https=)
CA (1) CA2594915A1 (https=)
MX (1) MX2007009137A (https=)
RU (1) RU2371433C2 (https=)
WO (1) WO2006081554A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2477604A1 (en) 2002-03-13 2003-09-25 Signum Biosciences, Inc. Modulation of protein methylation and phosphoprotein phosphate
MX2007008974A (es) * 2005-01-28 2007-09-18 Irm Llc Sintesis de aril-pirrolidonas.
US7923041B2 (en) 2005-02-03 2011-04-12 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
WO2006084033A1 (en) 2005-02-03 2006-08-10 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
JP5164510B2 (ja) * 2006-10-06 2013-03-21 日本曹達株式会社 含窒素複素環化合物および有害生物防除剤
US8455513B2 (en) 2007-01-10 2013-06-04 Aerie Pharmaceuticals, Inc. 6-aminoisoquinoline compounds
JP5607025B2 (ja) 2008-04-21 2014-10-15 シグナム バイオサイエンシーズ， インコーポレイテッド 化合物、組成物およびそれらを作製する方法
US8450344B2 (en) 2008-07-25 2013-05-28 Aerie Pharmaceuticals, Inc. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
CN101747253B (zh) * 2008-12-02 2013-01-16 中国人民解放军军事医学科学院毒物药物研究所 三取代的手性内酰胺类衍生物及其制备方法和用途
EP3053913B1 (en) 2009-05-01 2018-03-07 Aerie Pharmaceuticals, Inc. Dual mechanism inhibitors for the treatment of disease
GB2497476B (en) * 2010-09-06 2018-01-10 Guangzhou Inst Biomed & Health Amide Compounds
CN101979378B (zh) * 2010-10-13 2012-06-27 中国科学院上海有机化学研究所 一种手性γ-内酰胺化合物的合成方法
DK3811943T3 (da) 2013-03-15 2023-04-03 Aerie Pharmaceuticals Inc Forbindelse til anvendelse til behandling af øjenlidelser
KR102568079B1 (ko) 2016-08-31 2023-08-17 에어리 파마슈티컬즈, 인코포레이티드 안과용 조성물
KR20190135027A (ko) * 2017-03-31 2019-12-05 에어리 파마슈티컬즈, 인코포레이티드 아릴 시클로프로필-아미노-이소퀴놀리닐 아미드 화합물
EP3676255B1 (en) 2017-08-29 2025-04-16 Rutgers, The State University University Of New Jersey Therapeutic indazoles
AU2019337703B2 (en) 2018-09-14 2023-02-02 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds
WO2020113094A1 (en) 2018-11-30 2020-06-04 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU797219A1 (ru) * 1979-05-08 1995-07-25 Ленинградский государственный педагогический институт им.А.И.Герцена N-карбамоилметил-4-фенил-2-пирролидон, обладающий гипотензивной активностью
TW448172B (en) * 1996-03-08 2001-08-01 Pharmacia & Upjohn Co Llc Novel hydroxamic acid derivatives useful for the treatment of diseases related to connective tissue degradation
US7495016B2 (en) * 2002-10-21 2009-02-24 Irm Llc Pyrrolidones with anti-HIV activity

Also Published As

Publication number Publication date
KR100896889B1 (ko) 2009-05-14
RU2371433C2 (ru) 2009-10-27
KR20070103404A (ko) 2007-10-23
WO2006081554A3 (en) 2006-12-14
RU2007132259A (ru) 2009-03-10
CA2594915A1 (en) 2006-08-03
EP1841425A2 (en) 2007-10-10
WO2006081554A2 (en) 2006-08-03
CN101115481A (zh) 2008-01-30
JP2008528624A (ja) 2008-07-31
EP1841425A4 (en) 2009-02-18
MX2007009137A (es) 2007-09-12
AU2006209245A1 (en) 2006-08-03
BRPI0606123A2 (pt) 2009-06-02
US20080287516A1 (en) 2008-11-20

Similar Documents

Publication Publication Date Title
KR100896889B1 (ko) 페닐-치환 피롤리돈
US7601742B2 (en) Pyrrolidones with anti-HIV activity
US7205328B2 (en) Oxindoles with anti-HIV activity
JP7297053B2 (ja) 神経変性疾患を治療するためのｅ３ユビキチンリガーゼ結合活性を有するキメラ（ｐｒｏｔａｃ）化合物を標的とし、アルファ－シヌクレインタンパク質を標的とするタンパク質分解
KR100802368B1 (ko) 세포 증식의 억제제로서의 이미다졸로-5-일-2-아닐리노-피리미딘
CA2496565C (en) Non-nucleoside reverse transcriptase inhibitors
BG62488B1 (bg) Сулфонамиди като инхибитори на hiv аспартилпротеаза
He et al. Design, synthesis and biological evaluation of 3-substituted 2, 5-dimethyl-N-(3-(1H-tetrazol-5-yl) phenyl) pyrroles as novel potential HIV-1 gp41 inhibitors
EA017405B1 (ru) Соединения и композиции в качестве ингибиторов протеинкиназы
KR20110053379A (ko) 아미노 치환 벤조일 유도체군, 그리고 이의 제조 및 용도
CA2368041A1 (en) Indolinone compounds as kinase inhibitors
US7019141B2 (en) Quinolones with anti-HIV activity
ES2360818T3 (es) Miméticos de urea lineal antagonistas del receptor p2y, útiles en el tratamiento de afecciones trombóticas.
JP2018505194A (ja) ネクロプトーシスの阻害剤
CN114634496B (zh) 吲哚酮取代-1,3-噻唑烷酮类衍生物及其制备方法和应用
CN101497580A (zh) Hiv-1抑制剂吡咯酮衍生物及其合成方法和应用
HUT65911A (en) Process for preparing hydroxy-ethylene-isoster-tupe compounds containing dithiolanyl-glycine and pharmaceutical compositions containing them
Zhou et al. Piperidine scaffold as the novel P2-ligands in cyclopropyl-containing HIV-1 protease inhibitors: Structure-based design, synthesis, biological evaluation and docking study
JPH04305578A (ja) ベンゾジアゼピン、その製造法、及び薬剤としての利用
CN101309911A (zh) Hiv-1蛋白酶抑制剂及其制备方法和使用方法
WO2024263781A1 (en) Targeted degraders of hiv-1 nef for the treatment of hiv disease
CN112724148A (zh) 一种咪唑并哒嗪类化合物及修饰后的双亲功能分子及其应用
CN121969608A (zh) 用于治疗HIV疾病的HIV-1 Nef靶向降解剂
CA2184146A1 (en) Heterocyclically substituted pseudopeptides

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20090305

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20090420

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20091001

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20090420

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I